Distribution of


Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
15 06 2022
Historique:
pubmed: 6 5 2022
medline: 18 6 2022
entrez: 5 5 2022
Statut: ppublish

Résumé

Achromobacter spp. are nonfermenting Gram-negative bacilli mainly studied among cystic fibrosis (CF) patients. The identification of the 19 species within the genus is time-consuming (

Identifiants

pubmed: 35510500
doi: 10.1128/jcm.02422-21
pmc: PMC9199411
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0242221

Références

Microb Genom. 2021 Jul;7(7):
pubmed: 34292148
Rev Argent Microbiol. 2020 Jan - Mar;52(1):13-18
pubmed: 31253503
Epidemiol Infect. 2017 Feb;145(3):600-606
pubmed: 27873565
J Clin Microbiol. 2017 Jul;55(7):2074-2085
pubmed: 28446570
J Cyst Fibros. 2020 May;19(3):388-393
pubmed: 31862307
Front Cell Infect Microbiol. 2017 May 29;7:224
pubmed: 28611955
J Clin Microbiol. 2021 Sep 20;59(10):e0094621
pubmed: 34346714
Clin Microbiol Infect. 2021 Jan;27(1):126.e1-126.e5
pubmed: 32283265
BMC Microbiol. 2016 Jun 24;16(1):122
pubmed: 27342812
Int J Syst Evol Microbiol. 2020 Jan;70(1):530-536
pubmed: 31613739
Ann Am Thorac Soc. 2017 Sep;14(9):1412-1418
pubmed: 28406714
J Clin Microbiol. 2011 Oct;49(10):3649-51
pubmed: 21849686
J Cyst Fibros. 2013 May;12(3):298-301
pubmed: 23141756
J Med Microbiol. 2017 May;66(5):686-689
pubmed: 28481740
J Cyst Fibros. 2016 Jul;15(4):479-85
pubmed: 26412052
J Clin Microbiol. 2013 Jun;51(6):1927-30
pubmed: 23536401
J Clin Microbiol. 2015 Dec;53(12):3894-6
pubmed: 26400790
Infect Genet Evol. 2015 Jun;32:214-23
pubmed: 25791931
J Clin Microbiol. 2021 Mar 19;59(4):
pubmed: 33472899
J Clin Microbiol. 2012 Sep;50(9):3010-5
pubmed: 22785192
J Clin Microbiol. 2012 Aug;50(8):2688-94
pubmed: 22675125
J Cyst Fibros. 2019 Nov;18(6):804-807
pubmed: 31104975
BMC Genomics. 2018 Feb 9;19(Suppl 3):74
pubmed: 29504898
J Cyst Fibros. 2016 Jul;15(4):486-94
pubmed: 26778615

Auteurs

Thomas Garrigos (T)

Department of Bacteriology, University Hospital of Dijon, Dijon, France.
UMR/CNRS 6249 Chrono-environnement, University of Bourgogne-Franche-Comté, Besançon, France.

Manon Dollat (M)

Department of Bacteriology, University Hospital of Dijon, Dijon, France.

Arnaud Magallon (A)

Department of Bacteriology, University Hospital of Dijon, Dijon, France.
UMR/CNRS 6249 Chrono-environnement, University of Bourgogne-Franche-Comté, Besançon, France.

Anaïs Folletet (A)

Department of Bacteriology, University Hospital of Dijon, Dijon, France.

Julien Bador (J)

Department of Bacteriology, University Hospital of Dijon, Dijon, France.
UMR/CNRS 6249 Chrono-environnement, University of Bourgogne-Franche-Comté, Besançon, France.

Maryam Abid (M)

Department of Bacteriology, Virology, Hospital Hygiene, Tours University Hospital, Tours, France.

Marlène Amara (M)

Department of Microbiology, Hospital of Versailles, Le Chesnay, France.

Clémence Beauruelle (C)

INSERM, EFS, Univ Brest, UMR 1078, GGB, Brest, France.
Department of Bacteriology, Virology, Hospital Hygiene, and Parasitology-Mycology, Brest University Hospital, Boulevard Tanguy Prigent, Brest, France.

Olivier Belmonte (O)

Bacteriology Laboratory, Felix-Guyon University Hospital, Saint-Denis, France.

Pierre Boyer (P)

Bacteriology Department, Strasbourg University Hospital, Strasbourg, France.
UR7290 Early Bacterial Virulence, Institute of Bacteriology, ITI InnoVec, Fédération de Médecine Translationnelle de Strasbourg, University of Strasbourg, Strasbourg, France.

Emilie Cardot-Martin (E)

Department of Microbiology, Foch Hospital, Suresnes, France.

Anne-Gaëlle Cauchie (AG)

Department of Microbiology, Hospital of Versailles, Le Chesnay, France.

Sylvie Colin de Verdière (S)

Respiratory Diseases Department and Centre de compétence de la Mucoviscidose, Foch Hospital, Suresnes, France.

Claire Daurel (C)

Microbiology Department, CHU de Caen, Caen, France.

Cécile Gaudru (C)

Department of Bacteriology, Purpan University Hospital, Toulouse, France.
IRSD, Toulouse University, INSERM, INRA, ENVT, UPS, Toulouse, France.

Farida Hamdad (F)

Department of Bacteriology, Amiens University Hospital, Amiens, France.

Geneviève Héry-Arnaud (G)

INSERM, EFS, Univ Brest, UMR 1078, GGB, Brest, France.
Department of Bacteriology, Virology, Hospital Hygiene, and Parasitology-Mycology, Brest University Hospital, Boulevard Tanguy Prigent, Brest, France.

Baptiste Hoellinger (B)

Bacteriology Department, Strasbourg University Hospital, Strasbourg, France.

Claudie Lamoureux (C)

INSERM, EFS, Univ Brest, UMR 1078, GGB, Brest, France.
Department of Bacteriology, Virology, Hospital Hygiene, and Parasitology-Mycology, Brest University Hospital, Boulevard Tanguy Prigent, Brest, France.

Marie-Frédérique Lartigue (MF)

Department of Bacteriology, Virology, Hospital Hygiene, Tours University Hospital, Tours, France.
INRAE, ISP, Tours University, Tours, France.

Damasie Malandain (D)

Microbiology Department, CHU de Caen, Caen, France.

Océane Marchand (O)

Department of Microbiology, Toulon-La Seyne-sur-Mer Hospital, Toulon, France.

Caroline Piau (C)

Department of Clinical Microbiology, Rennes University Hospital, Rennes, France.

Sandrine Picot (S)

Department of Bacteriology, Virology and Parasitology, University Hospital of La Réunion, Saint Pierre, Réunion.

Hélène Revillet (H)

Department of Bacteriology, Purpan University Hospital, Toulouse, France.
IRSD, Toulouse University, INSERM, INRA, ENVT, UPS, Toulouse, France.
Observatoire Burkholderia cepacia, Toulouse University Hospital, Toulouse/Vaincre la Mucoviscidose, Paris, France.

Zeina Sabouni (Z)

Department of Microbiology, Toulon-La Seyne-sur-Mer Hospital, Toulon, France.

Catherine Neuwirth (C)

Department of Bacteriology, University Hospital of Dijon, Dijon, France.
UMR/CNRS 6249 Chrono-environnement, University of Bourgogne-Franche-Comté, Besançon, France.

Lucie Amoureux (L)

Department of Bacteriology, University Hospital of Dijon, Dijon, France.
UMR/CNRS 6249 Chrono-environnement, University of Bourgogne-Franche-Comté, Besançon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH